Biblio
Export 1237 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is D [Clear All Filters]
“Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 71, no. 1, pp. 281-290, 2019.
, “APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
, “Association between Adipokines and Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 67, no. 2, pp. 725-735, 2019.
, “Can Subjective Memory Complaints Identify Aβ Positive and Aβ Negative Amnestic Mild Cognitive Impairment Patients?”, J Alzheimers Dis, vol. 70, no. 4, pp. 1103-1111, 2019.
, “Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?”, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
, “Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?”, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
, “Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?”, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
, “Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.”, J Alzheimers Dis, vol. 70, no. 1, pp. 35-49, 2019.
, “Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways.”, J Alzheimers Dis, vol. 68, no. 2, pp. 657-668, 2019.
, “Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways.”, J Alzheimers Dis, vol. 68, no. 2, pp. 657-668, 2019.
, “Ethical Issues in the Treatment of Late-Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1311-1316, 2019.
, “Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures.”, J Alzheimers Dis, vol. 70, no. 3, pp. 659-666, 2019.
, “Evaluation of Medicare Claims Data as a Tool to Identify Dementia.”, J Alzheimers Dis, vol. 67, no. 2, pp. 769-778, 2019.
, “Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial.”, J Alzheimers Dis, vol. 71, no. 2, pp. 421-433, 2019.
, “Gender and Educational Differences in the Association between Lifestyle and Cognitive Decline over 10 Years: The Doetinchem Cohort Study.”, J Alzheimers Dis, vol. 70, no. s1, pp. S31-S41, 2019.
, “Genome-Wide Methylation of Mild Cognitive Impairment in Mexican Americans Highlights Genes Involved in Synaptic Transport, Alzheimer's Disease-Precursor Phenotypes, and Metabolic Morbidities.”, J Alzheimers Dis, vol. 72, no. 3, pp. 733-749, 2019.
, “Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.”, J Alzheimers Dis, vol. 67, no. 2, pp. 481-488, 2019.
, “Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.”, J Alzheimers Dis, vol. 67, no. 2, pp. 481-488, 2019.
, “Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD +/NADH Redox Sites.”, J Alzheimers Dis, vol. 71, no. 1, pp. 119-140, 2019.
, “Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype.”, J Alzheimers Dis, vol. 69, no. 1, pp. 145-156, 2019.
, “Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life.”, J Alzheimers Dis, vol. 69, no. 3, pp. 817-827, 2019.
, “Impacts of Overweight and Obesity in Older Age on the Risk of Dementia: A Systematic Literature Review and a Meta-Analysis.”, J Alzheimers Dis, vol. 70, no. s1, pp. S87-S99, 2019.
, “Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.”, J Alzheimers Dis, vol. 72, no. 1, pp. 301-318, 2019.
, “Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.”, J Alzheimers Dis, vol. 69, no. 4, pp. 1077-1087, 2019.
,